fda approvals in ovarian cancer, merkel cell carcinoma, itp, and more
Published 5 years ago • 141 plays • Length 10:39Download video MP4
Download video MP3
Similar videos
-
7:01
fda approvals in ovarian cancer and merkel cell carcinoma
-
0:35
dr. kudchadkar on the fda approval of avelumab in merkel cell carcinoma
-
1:42
dr. hamid on the fda approval of pembrolizumab in merkel cell carcinoma
-
6:31
fda d.i.s.c.o.: avelumab in merkel cell carcinoma transcript
-
6:31
fda d.i.s.c.o.: avelumab in merkel cell carcinoma
-
2:19
dr. arend on fda approval of frontline bevacizumab in ovarian cancer
-
8:21
fda approval of a biosimilar, priority review in epithelioid sarcoma, and more
-
6:31
fda d.i.s.c.o.: fda approval of cemiplimab-rwlc for cutaneous squamous cell carcinoma
-
1:36
avelumab and pembrolizumab for the treatment of merkel cell carcinoma
-
1:06
managing avelumab side effects in patients with merkel cell carcinoma
-
1:03
role of immunotherapy in merkel cell carcinoma
-
54:34
uncovering merkel cell polyomavirus
-
1:08
dr. kaufman on avelumab in merkel cell carcinoma
-
3:19
labs in action: a new immunotherapy treatment for merkel cell carcinoma
-
3:00
regulation of pd-l1 in cutaneous lymphoma by mirnas
-
1:09
new standard of care for merkel cell carcinoma
-
2:10
proclipi: registry & establishment of a prognostic index for mf and ss
-
51:06
merkel cell carcinoma: from diagnosis to treatment